Hematologic and immunologic aberrations in patients under diphenylhydantoin administration.
D000293:Adolescent; D000368:Aged; D000927:Anticonvulsants / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000139:chemically induced; D005260:Female; D006801:Humans; D007244:Infectious Mononucleosis / Q000139:chemically induced*; D008223:Lymphoma / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D010672:Phenytoin / Q000009:adverse effects*
D000927:Anticonvulsants; D010672:Phenytoin